BA
CRBP icon

BlackRock Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

BlackRock Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$52K Hold
205
– – ﹤0.01% 3246
2016
Q3 		$42K Hold
205
– – ﹤0.01% 3299
2016
Q2 		$18K Hold
205
– – ﹤0.01% 3467
2016
Q1 		$11K Hold
205
– – ﹤0.01% 3559
2015
Q4 		$10K Hold
205
– – ﹤0.01% 3624
2015
Q3 		$10K Buy
205
+140
+215% +$9.32K ﹤0.01% 3654
2015
Q2 		$6K Buy
+65
New +$6.54K ﹤0.01% 3653

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BlackRock Advisors's CRBP Position: Q4 2016 in Review

BlackRock Advisors held its Corbus Pharmaceuticals (CRBP) position steady in Q4 2016 at 205 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

BlackRock Advisors first reported a position in CRBP in Q2 2015 and has held it in 7 quarters since. 49 funds tracked by Wall St. Rank hold CRBP as of Q4 2016.

  • BlackRock Advisors held 205 shares of Corbus Pharmaceuticals worth $52K as of Q4 2016.
  • BlackRock Advisors left its Corbus Pharmaceuticals share count unchanged in Q4 2016.
  • Corbus Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3246 holding.
  • BlackRock Advisors first reported a position in Corbus Pharmaceuticals in Q2 2015 and has held it in 7 quarters since.
  • 49 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.